TOKYO - Japan is set to approve the first domestically developed coronavirus vaccine after a health ministry panel of experts on Monday endorsed Daiichi Sankyo Co.'s plan to manufacture and sell the drug.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
